Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-24 @ 7:22 PM
NCT ID:
NCT01059903
Eligibility Criteria:
Inclusion Criteria:
* Healthy White, male volunteers between 18 and 55 years of age (inclusive).
* BMI between 19 and 28 kg/m\^2 (inclusive)
Exclusion Criteria:
* Previous participation in a clinical study with Rotigotine
* History or current condition of epilepsy and/or seizures
* Known clinically relevant allergy or known/suspected clinically relevant drug hypersensitivity
* History of significant skin hypersensitivity to adhesives or other transdermal products or recently unresolved contact dermatitis
* History or present condition of an atopic or eczematous dermatitis, psoriasis, and/or an active skin disease
* Clinically relevant abnormality in physical examination, ECG, vital signs or safety laboratory examinations
* Positive HIV, hepatitis B or C test or positive alcohol or drug test
* Relevant hepatic or renal dysfunction
* Intake of medication that might interfere with the test drug within 2 weeks prior to dosing
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT01059903
Study Brief:
Protocol Section:
NCT01059903